av/avalo-therapeutics--big.svg

COM:AVALOTX

Avalo Therapeutics, Inc.

  • Stock

USD

Last Close

9.65

22/11 21:00

Market Cap

12.97M

Beta: -

Volume Today

80.44K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
1.15M
-
27.81M
2,312.24%
18.33M
34.11%
6.75M
63.17%
6.70M
0.76%
5.40M
19.42%
18.05M
234.40%
1.41M
92.20%
cost of revenue
635.65K
-
7.48M
1,076.48%
-567K
107.58%
300K
152.91%
1.49M
397%
3.43M
130.32%
1.28M
62.61%
gross profit
1.15M
-
27.18M
2,257.11%
10.85M
60.08%
7.32M
32.55%
6.40M
12.55%
3.91M
38.94%
14.62M
274.12%
124K
99.15%
selling and marketing expenses
973.35K
-
8.52M
775.58%
1.48M
82.59%
2.34M
57.75%
2.83M
20.72%
76K
97.31%
general and administrative expenses
4.02M
-
4.88M
21.26%
4.42M
9.27%
7.08M
60.14%
7.94M
12.12%
10.68M
34.44%
10.12M
5.18%
17.42M
72.05%
21.83M
25.34%
20.64M
5.48%
selling general and administrative expenses
4.02M
-
4.88M
21.26%
4.42M
9.27%
7.08M
60.14%
8.91M
25.86%
19.20M
115.36%
11.61M
39.54%
19.76M
70.22%
24.66M
24.79%
20.71M
16.01%
10.30M
50.27%
research and development expenses
8.91M
-
12.24M
37.32%
6.59M
46.19%
10.15M
54.09%
4.37M
56.92%
5.79M
32.34%
11.76M
103.30%
32.19M
173.66%
59.84M
85.86%
31.31M
47.68%
13.78M
55.97%
other expenses
13.66K
-
1.34M
9,704.50%
1.74M
30.02%
1.55M
11.09%
38K
97.55%
3.91M
10,181.58%
cost and expenses
12.93M
-
17.12M
32.33%
11.01M
35.67%
17.23M
56.52%
13.92M
19.21%
37.00M
165.72%
24.14M
34.74%
53.99M
123.63%
87.53M
62.12%
55.49M
36.60%
29.27M
47.24%
operating expenses
12.93M
-
17.12M
32.33%
11.01M
35.67%
17.23M
56.52%
13.29M
22.89%
29.52M
122.15%
24.71M
16.29%
53.69M
117.28%
86.04M
60.25%
52.06M
39.50%
27.99M
46.23%
interest expense
10.55K
-
-1.21M
11,527.64%
-793.21K
34.24%
-464.18K
41.48%
-24.02K
94.83%
-811.62K
3,279.50%
-2.39M
-
4.17M
274.40%
-3.42M
181.94%
ebitda
-12.79M
-
-19.35M
51.27%
-12.32M
36.32%
-16.15M
31.08%
14.35M
188.81%
6.50M
54.66%
-17.36M
366.93%
-25.21M
45.22%
-80.59M
219.63%
-37.42M
53.56%
-27.87M
25.53%
operating income
-12.93M
-
-17.12M
32.33%
-11.01M
35.67%
-16.08M
46.05%
13.89M
186.38%
-39.31M
383.04%
-17.39M
55.76%
-26.95M
54.96%
-82.13M
204.73%
-37.44M
54.42%
-27.87M
25.57%
depreciation and amortization
20.03K
-
28.94K
44.48%
23.51K
18.78%
26.86K
14.24%
425.48K
1,484.29%
4.55M
970.56%
33K
99.28%
1.74M
5,175.76%
1.55M
11.09%
18K
98.84%
total other income expenses net
-121.11K
-
2.27M
1,971.08%
1.31M
42.06%
73K
94.44%
-29.62K
140.58%
-20.61M
69,455.81%
1.40M
106.81%
-40.22M
2,967.00%
-2.41M
94.01%
-4.19M
73.79%
-3.66M
12.58%
income before tax
-13.05M
-
-16.06M
23.08%
-10.49M
34.66%
-16.47M
57.02%
13.84M
184.00%
-40.09M
389.72%
-15.99M
60.11%
-67.18M
320.09%
-84.55M
25.85%
-41.63M
50.76%
-31.53M
24.26%
income tax expense
110.56K
-
-1.06M
1,058.73%
-543.51K
48.72%
364.14K
167.00%
1.97M
440.04%
-33.91K
101.72%
280K
925.72%
-2.79M
1,097.50%
-196K
92.98%
28K
114.29%
14K
50%
net income
-13.05M
-
-16.06M
23.08%
-10.49M
34.66%
-16.47M
57.02%
11.87M
172.06%
-40.05M
437.43%
-16.27M
59.38%
-64.38M
295.70%
-84.35M
31.01%
-41.66M
50.61%
-31.54M
24.28%
weighted average shs out
385.85K
-
385.85K
0%
185.50K
51.92%
735.87K
296.69%
1.53M
108.48%
2.90M
88.88%
3.57M
23.31%
5.56M
55.53%
8.69M
56.29%
9.40M
8.27%
weighted average shs out dil
385.85K
-
385.85K
0%
185.50K
51.92%
735.87K
296.69%
1.56M
112.39%
2.90M
85.41%
3.57M
23.31%
5.56M
55.53%
8.69M
56.29%
9.40M
8.27%
eps
-33.81
-
-41.61
23.07%
-56.55
35.90%
-22.38
60.42%
5.04
122.52%
-13.82
374.21%
-4.55
67.08%
-11.59
154.73%
-9.71
16.22%
-4.43
54.38%
-114
2,473.36%
epsdiluted
-33.81
-
-41.61
23.07%
-56.55
35.90%
-22.38
60.42%
5.04
122.52%
-13.82
374.21%
-4.55
67.08%
-11.59
154.73%
-9.71
16.22%
-4.43
54.38%
-114
2,473.36%

All numbers in USD (except ratios and percentages)